This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CVS/pharmacy Expands ExtraCare Advantage For Diabetes® Program With New Support And Savings For The 26 Million Americans Living With Diabetes

Since its launch in 2010, the CVS/pharmacy ExtraCare Advantage for Diabetes program has helped more than 2 million members save money and better manage the disease. The program is free and open to all members of the CVS/pharmacy ExtraCare savings and rewards program; cardholders can easily sign up at Once enrolled, patients and caregivers can earn ExtraBucks ® Rewards on more than 100 products used to manage diabetes, including testing supplies, glucose test strips and glucose meters. In addition to exclusive savings, members also have access to a variety of resources including an "Ask Our Pharmacist" section, additional offers, videos and recipes addressing their specific lifestyle needs. Members can log on to or access the CVS mobile app to view what personalized ExtraSavings™ and ExtraBucks Rewards are currently available, and choose to "Print" or "Send to Card" their coupon savings and ExtraBucks   Rewards. 

In addition to earning ExtraBucks Rewards that can be spent on most items in the store, ExtraCare Advantage for Diabetes members receive special offers and discounts on their receipts and at the in-store ExtraCare Coupon Center. Members can visit the Information & Advice center on, which features videos and answers from the pharmacist year round.

For more information, visit

About CVS/pharmacy

CVS/pharmacy, the retail division of CVS Caremark Corporation (NYSE: CVS), is America's leading retail pharmacy with 7,400 CVS/pharmacy and Longs Drug stores. CVS/pharmacy is reinventing pharmacy to help people on their path to better health by providing the most accessible and personalized expertise, both in its stores and online at General information about CVS/pharmacy and CVS Caremark is available at

Press Contacts:       

Erin PensaCVS/pharmacyT: 401.770.4786E:

Michael DeAngelisCVS/pharmacyT: 401.770.2645E:

SOURCE CVS/pharmacy

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,859.29 +139.37 0.79%
S&P 500 2,097.90 +17.49 0.84%
NASDAQ 5,144.4170 +35.7510 0.70%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs